IGM Biosciences Quote - IGMS

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

6.51

Bid

6.50

Ask

6.70

Volume

400,237

6.455 Day's Range 7.41

3.81 52 Week Range 17.70

Market Cap

382.113M

Previous Close

7.24

Open

7.15

Last Trade

6.51

Last Trade Time

15:41:35

Financial Volume

US$ 2,702,197

VWAP

6.7515

Average Volume (3m)

325,237

Shares Outstanding

58,786,588

Dividend Yield

PE Ratio

-1.55

Earnings Per Share (EPS)

-4.19

Revenue

2.13M

Net Profit

-246.42M

IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking ago... IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists, and targeted cytokines. Its product candidate, IGM-2323, is a bispecific T cell engaging IgM antibody targeting CD20 and CD3 protein, IGM-8444, a combination with a chemotherapeutic agent such as irinotecan, gemcitabine, or venetoclax, and IGM-7354, a bispecific IgM antibody delivering interleukin-15 (IL-15) cytokines to PD-L1 expressing cells for the treatment of patients with solid and hematologic malignancies. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.igmbio.com

Headquarters

Dover, Delaware, USA

Founded

1970

IGM Biosciences Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker IGMS. The last closing price for IGM Biosciences was US$7.24. Over the last year, IGM Biosciences shares have traded in a share price range of US$ 3.81 to US$ 17.70.

IGM Biosciences currently has 58,786,588 shares outstanding. The market capitalization of IGM Biosciences is US$382.11 million. IGM Biosciences has a price to earnings ratio (PE ratio) of -1.55.

Form SC TO-I - Tender offer statement by Issuer

Form 4 - Statement of changes in beneficial ownership of securities

Period †	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-1.54	-19.1304347826	8.05	8.24	6.455	204345	7.39145761	CS
4	-5	-43.4404865334	11.51	11.595	6.455	303364	8.34605806	CS
12	-2.77	-29.849137931	9.28	12.31	6.39	325237	9.1276325	CS
26	-1.31	-16.7519181586	7.82	17.7	6.39	307327	10.44842324	CS
52	-3.17	-32.7479338843	9.68	17.7	3.81	315375	8.74236059	CS
156	-78.67	-92.3573608828	85.18	93.98	3.81	336485	21.20133481	CS
260	-11.8	-64.4456581103	18.31	127.11	3.81	273823	31.14939158	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
GRCGold Springs Resource Corp	$ 0.09 (20.00%)	255.2k
SFDNXT Energy Solutions Inc	$ 0.16 (18.52%)	118k
SAMStarcore International Mines Ltd	$ 0.14 (16.67%)	525
DSVDiscovery Silver Corp	$ 1.03 (13.19%)	913.48k
PYRPyroGenesis Canada Inc	$ 0.69 (13.11%)	191.75k
CFXCanfor Pulp Products Inc	$ 1.04 (-25.71%)	141.77k
AEZSAeterna Zentaris Inc	$ 6.04 (-24.50%)	14.45k
LPENLoop Energy Inc	$ 0.025 (-16.67%)	15.04k
ETEvertz Technologies Ltd	$ 13.30 (-13.30%)	120.44k
AABAberdeen International Inc	$ 0.035 (-12.50%)	1.61M
CNQCanadian Natural Resources Ltd	$ 47.87 (1.36%)	29.03M
TRPTC Energy Corporation	$ 52.25 (-0.08%)	14.09M
SUSuncor Energy Inc	$ 50.82 (0.08%)	8.95M
MFCManulife Financial Corporation	$ 35.23 (0.46%)	7.75M
POWPower Corp of Canada	$ 37.57 (-0.71%)	6.65M